Drug Susceptibility Testing for Optimizing Tuberculosis Treatment

E-ISSN： 1873-4286|17|27|2863-2874

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.27, 2011-09, pp. : 2863-2874

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selected culture and drug-susceptibility testing methods for drug-resistant Mycobacterium tuberculosis screening in resource-constrained settings

By Ausina Ruiz Vicente Fernández-Rivas Gema Vilaplana Messeguer Cristina

Expert Review of Molecular Diagnostics, Vol. 13, Iss. 3, 2013-04 ,pp. : 247-249

Informa Healthcare

Access to resources Recommend Favorite

Tuberculosis susceptibility – implications for drug development and therapy

By Snell Noel J C

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 9, 2003-09 ,pp. : 1455-1460

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Drug Monitoring in the Treatment of Tuberculosis

By Peloquin C.A.

Drugs, Vol. 62, Iss. 15, 2002-01 ,pp. : 2169-2183

Adis International

Access to resources Recommend Favorite

Drug Treatment for Tuberculosis during Pregnancy: Safety Considerations

By Bothamley G.

Drug Safety, Vol. 24, Iss. 7, 2001-01 ,pp. : 553-565

Adis International

Access to resources Recommend Favorite

Pharmacokinetic Factors in the Modern Drug Treatment of Tuberculosis

By Graham Douglas J. McLeod M-J.

Clinical Pharmacokinetics, Vol. 37, Iss. 2, 1999-08 ,pp. : 127-146

Adis International

Access to resources Recommend Favorite